according ap neuronetics hear word fda january regarding whether transcranial magnetic stimulation tms treatment receive fda approval treating depression may recall previous date fda approval delayed tms scheduled fda decision october according ap fda postponed meeting due general scheduling conflicts according malvern pennsylvania based neuronetics insist buy story brief review tms therapy